Effect of decreased renal function on poor oncological outcome after radical cystectomy

被引:3
作者
Kim, Dongsu [1 ]
Nam, Wook [2 ]
Kyung, Yoon Soo [1 ]
You, Dalsan [1 ]
Jeong, In Gab [1 ]
Hong, Bumsik [1 ]
Hong, Jun Hyuk [1 ]
Ahn, Hanjong [1 ]
Lim, Bumjin [1 ,3 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Urol, Seoul, South Korea
[2] Univ Ulsan, Gangneung Asan Hosp, Dept Urol, Coll Med, Kangnung, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Urol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
关键词
Bladder cancer; Glomerular filtration rates; Patient outcome assessment; INVASIVE BLADDER-CANCER; CHRONIC KIDNEY-DISEASE; CISPLATIN-BASED CHEMOTHERAPY; TRANSITIONAL-CELL CARCINOMA; GLOMERULAR-FILTRATION-RATE; RISK-FACTOR; RECURRENCE; PROGRESSION; ELIGIBILITY; PATTERNS;
D O I
10.4111/icu.20230063
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To evaluate the impact of preoperative renal impairment on the oncological outcomes of patients with urothelial carci-noma who underwent radical cystectomy.Materials and Methods: We retrospectively reviewed the medical records of patients with urothelial carcinoma who underwent radical cystectomy from 2004 to 2017. All patients who underwent preoperative 99mTc-diethylenetriaminepentaacetic acid renal scintigraphy (DTPA) were identified. We divided the patients into two groups according to their glomerular filtration rates (GFRs): GFR group 1, GFR>_90 mL/min/1.73 m2; GFR group 2, 60<_GFR<90 mL/min/1.73 m2. We included 89 patients in GFR group 1 and 246 patients in GFR group 2 and compared the clinicopathological characteristics and oncological outcomes between the two groups.Results: The mean time required for recurrence was 125.5 & PLUSMN;8.0 months in GFR group 1 and 85.7 & PLUSMN;7.4 months in GFR group 2 (p=0.030). The mean cancer-specific survival was 131.7 & PLUSMN;7.8 months in GFR group 1 and 95.5 & PLUSMN;6.9 months in GFR group 2 (p=0.051). The mean overall survival was 123.3 & PLUSMN;8.1 months in GFR group 1 and 79.5 & PLUSMN;6.6 months in GFR group 2 (p=0.004).Conclusions: Preoperative GFR values in the range of 60<_GFR<90 mL/min/1.73 m2 are independent prognostic factors for poor recurrence-free survival, cancer-specific survival, and overall survival in patients after radical cystectomy compared with GFR val-ues of >_90 mL/min/1.73 m2.
引用
收藏
页码:346 / 352
页数:7
相关论文
共 30 条
  • [11] Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer
    Hatakeyama, Shingo
    Koie, Takuya
    Narita, Takuma
    Hosogoe, Shogo
    Yamamoto, Hayato
    Tobisawa, Yuki
    Yoneyama, Tohru
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Ohyama, Chikara
    [J]. PLOS ONE, 2016, 11 (02):
  • [12] Urinary diversion: Ileal conduit to neobladder
    Hautmann, RE
    [J]. JOURNAL OF UROLOGY, 2003, 169 (03) : 834 - 842
  • [13] Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.21492, 10.3322/caac.20107]
  • [14] Aspects of immune dysfunction in end-stage renal disease
    Kato, Sawako
    Chmielewski, Michal
    Honda, Hirokazu
    Pecoits-Filho, Roberto
    Matsuo, Seiichi
    Yuzawa, Yukio
    Tranaeus, Anders
    Stenvinkel, Peter
    Lindholm, Bengt
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (05): : 1526 - 1533
  • [15] Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature
    Kluth, Luis A.
    Black, Peter C.
    Bochner, Bernard H.
    Catto, James
    Lerner, Seth P.
    Stenzl, Arnulf
    Sylvester, Richard
    Vickers, Andrew J.
    Xylinas, Evanguelos
    Shariat, Shahrokh F.
    [J]. EUROPEAN UROLOGY, 2015, 68 (02) : 238 - 253
  • [16] Chronic kidney disease as a risk factor for recurrence and progression in patients with primary non-muscle-invasive bladder cancer
    Kobatake, Kohei
    Hayashi, Tetsutaro
    Black, Peter C.
    Goto, Keisuke
    Sentani, Kazuhiro
    Kaneko, Mayumi
    Yasui, Wataru
    Mita, Koji
    Teishima, Jun
    Matsubara, Akio
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (08) : 594 - 600
  • [17] Feasibility of Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer Patients With Diminished Renal Function
    Koshkin, Vadim S.
    Barata, Pedro C.
    Rybicki, Lisa A.
    Zahoor, Haris
    Almassi, Nima
    Redden, Alicia M.
    Fergany, Amr F.
    Kaouk, Jihad
    Haber, Georges-Pascal
    Stephenson, Andrew J.
    Ornstein, Moshe C.
    Gilligan, Timothy
    Garcia, Jorge A.
    Rini, Brian, I
    Grivas, Petros
    [J]. CLINICAL GENITOURINARY CANCER, 2018, 16 (04) : E879 - E892
  • [18] Chronic kidney disease as an important risk factor for tumor recurrences, progression and overall survival in primary non-muscle-invasive bladder cancer
    Li, Chia-En
    Chien, Chia-Shen
    Chuang, Yao-Chi
    Chang, Ye-In
    Tang, Hsiu-Pei
    Kang, Chih-Hsiung
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2016, 48 (06) : 993 - 999
  • [19] Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature
    Mari, Andrea
    Campi, Riccardo
    Tellini, Riccardo
    Gandaglia, Giorgio
    Albisinni, Simone
    Abufaraj, Mohammad
    Hatzichristodoulou, Georgios
    Montorsi, Francesco
    van Velthoven, Roland
    Carini, Marco
    Minervini, Andrea
    Shariat, Shahrokh F.
    [J]. WORLD JOURNAL OF UROLOGY, 2018, 36 (02) : 157 - 170
  • [20] Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer
    Matsumoto, Akihiko
    Nakagawa, Tohru
    Kanatani, Atsushi
    Ikeda, Masaomi
    Kawai, Taketo
    Miyakawa, Jimpei
    Taguchi, Satoru
    Naito, Akihiro
    Otsuka, Masafumi
    Nakanishi, Yasukazu
    Suzuki, Motofumi
    Koga, Fumitaka
    Nagase, Yasushi
    Kondo, Yasushi
    Okaneya, Toshikazu
    Tanaka, Yoshinori
    Miyazaki, Hideyo
    Fujimura, Tetsuya
    Fukuhara, Hiroshi
    Kume, Haruki
    Igawa, Yasuhiko
    Homma, Yukio
    [J]. WORLD JOURNAL OF UROLOGY, 2018, 36 (02) : 249 - 256